廣聯工程控股(01413.HK)年度營收4.82億港元 同比增長18.99%
格隆匯6月29日丨廣聯工程控股(01413.HK)公佈,截至2021年3月31日止年度,公司收益為4.82億港元,同比增長18.99%;公司權益持有人應占年內溢利為3113.4萬港元;基本每股盈利4.07港仙。年內產生的非經常性上市開支約1430萬港元。
年度收益增加主要由於回顧年度內獲授的兩個大型項目所貢獻的收益所致。該兩個項目的估計合約金額分別約為3.29億港元及5040萬港元。其中一個項目於2020年8月動工,而另一個項目於2021年1月動工,於回顧年度的收入貢獻分別約6410萬港元及2040萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.